Pediatrics Cataract Surgery and IOL Implantation

Dear Dr. Renukaprasad A R, Congenital and childhood cataracts are a significant cause of visual impairment in children. However, due to the different etiomorphological characteristics of the condition, its management remains a challenge. Intraocular Lens (IOL) during cataract surgery is the most common means of optical correction in children beyond infancy. Despite several studies confirming the safety and effectiveness of IOLs for infants and children, concern remains about the unknown risks associated with an IOL over the life span of a child. To learn more about surgery and the post-operative management of IOL, join Dr. Suresh K Pandey , a renowned ophthalmologist, for a Surgical Suite session on " Pearls for Infantile and Pediatrics Cataract Surgery and IOL Implantation ", TODAY, at 5:00 PM IST. Click to Join   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Application of Lipid-based Nanoemulsion in Ophthalmology

Docplexus - India's Largest Online Community of Verified Doctors

Hi Renukaprasad A R, Are you aware of the nanotechnology-based advancements in DED management? Artificial tears are the primary treatment option for DED because they help with symptomatic relief. However, conventional formulations have poor bioavailability due to the complex ophthalmic structure and rapid tear turnover. Nanotechnology has the solution to this limitation. Here is an article on the overview of nanotechnology with particular emphasis on its application in ophthalmology and DED. Highlights - A brief overview of nanotechnology Different types of nanosystems Introduction to lipid-based nanocarriers (LNCs) Applications of LNCs Click to Read If you don't want to receive these emails in the future, please unsubscribe.

High Expenses Even with Public Health Insurance, and More

Hi Renukaprasad A R, Top Stories of The Day: High Expenses Even with Public Health Insurance Research and Diagnostic Labs for Monkeypox Detection Whole Blood Exchange Therapy for Alzheimer's Lack of Essential Immunization for 25 Million Children This Week's Trending News JUST for You. Watch 'Docplexus Health Minute' from Monday to Friday and 'Health Minute Highlights' on Saturday & Sunday! Watch News   Disclaimer: The Health Minute intends to update the medical community about the latest happenings from around the world, including relevant decisions taken by policy-makers. We do not endorse any individual, community, or political party. India's Largest Online Community Of Verified Doctors Pune - 411045, India Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

IOL Implantation in Pediatric Cataract

Dear Dr. Renukaprasad A R, Congenital and childhood cataracts are often associated with profound visual loss and extra-ocular comorbidities. Close collaboration within multidisciplinary teams is essential for accurate diagnosis and treatment. The management remains challenging due to the availability of various surgical techniques, intervention timings, and options for optical correction. Intraocular lenses (IOL) at the time of cataract surgery is becoming the most common means of optical correction in children beyond infancy. Join Dr. Suresh K Pandey, a renowned ophthalmologist, for a Surgical Suite session on " Pearls for Infantile and Pediatrics Cataract Surgery and IOL Implantation " on 23rd July 2022, 5:00 PM IST onwards. I'm Interested   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Cervical Cancer: Better Screening for Better Diagnosis!

Dear Dr. Renukaprasad A R, Cervical cancer is preventable if timely screening and intervention are undertaken; however, conventional methods often give false-positive or negative results that compromise the detection and treatment. Newer cytology screening methods have been developed to improve diagnostic ability. For more insights on " Cytology Vs. Pap Smear " in cervical cancers, join the exclusive webinar with Dr. Sambit Nanda, TODAY at 3:00 PM IST. Join the Session   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Managing DED After Refractive Surgery

Docplexus - India's Largest Online Community of Verified Doctors

Hi Renukaprasad A R, Why are preoperative tests for dry eye disease (DED) required for patients undergoing refractive surgery? Depending on the patient's condition, DED post-refractive surgery is a common consequence, which can last for six months or longer. Therefore, standard preoperative DED evaluations can significantly improve postoperative treatment. Watch this video for more information on the preoperative DED analysis, the examination of corneal nerve injury during surgery, the algorithmic technique for risk assessment, and treatment strategies for DED post-surgery. Highlights: DED etiology after refractive surgery Preoperative evaluation of the patient for DED Modern diagnostic techniques for evaluation Using algorithms to manage DED Management and treatment of dry eyes Click to Watch If you don't want to receive these emails in the future, please unsubscribe.

How Can Abemaciclib Play a Role in MBC?

Dear Dr. Renukaprasad A R, If cancer does not take a day off, then why should a CDK 4/6 inhibitor? Rapid cell proliferation and drug resistance make metastatic breast cancer (MBC) difficult to treat. Abemaciclib, the cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitor, works by blocking the action of an abnormal CDK 4/6 protein that causes cancer cell proliferation. As a result, the drug helps slow down or stop cancer cells from proliferating. Attend this exclusive webinar on the 21st of July 2022 at 07:00 PM IST with the renowned oncology experts, Dr. Shaheenah Dawood, Dr. Sudeep Gupta, Dr. Ashish Singh, Dr. B. K. Smruti, Dr. Shruti Kate, and Dr. Shirish Alurkar, to learn more about the clinical role of abemaciclib in treating MBC patients with poor prognosis. Session details : Abemaciclib - Different by design Responses in MBC patients Clinical case presentation on the role of abemaciclib by Dr. Shaheenah Dawood, Dr. Shruti Kate, Dr. Shirish Alurkar, and Dr. B. K. Smruti Q&A with the experts - Tailoring treatment in HR+ HER2- MBC patients based on poor prognostic factors We look forward to your enthusiastic participation! Join the Session   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*